Clonidine Versus Midazolam for Premedication
This study has been completed.
Sponsor:
University of Schleswig-Holstein
Information provided by:
University of Schleswig-Holstein
ClinicalTrials.gov Identifier:
NCT00638729
First received: March 12, 2008
Last updated: March 18, 2008
Last verified: February 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
alpha2-agonists like clonidine offer several useful effects that make these drugs an interesting alternative to benzodiazepines for pharmacological premedication. We therefore sought to determine the effect of pre-anesthetic medication with clonidine vs. midazolam in a randomized, double-blind, placebo controlled study. Effects of pre-anesthetic medication were assessed on (1) bispectral index (BIS),(2) sedation score and visual analog scales for anxiety and pain, (3) neuropsychologic tests to assess cognitive function and (4) circulating stress hormones.
| Condition | Intervention |
|---|---|
|
Anxiety Pain |
Drug: midazolam Drug: clonidine Drug: placebo |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Caregiver, Outcomes Assessor) Primary Purpose: Supportive Care |
| Official Title: | Effects of Clonidine and Midazolam Premedication on Bispectral Index and Recovery After Elective Surgery |
Resource links provided by NLM:
Further study details as provided by University of Schleswig-Holstein:
Primary Outcome Measures:
- Effect of premedication on bispectral index [ Time Frame: prior study medication until 2 h postoperatively ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Effect of premedication on postoperative recovery [ Time Frame: prior to study medication until 2 h postoperatively ] [ Designated as safety issue: No ]
| Enrollment: | 60 |
| Study Start Date: | August 2005 |
| Study Completion Date: | March 2007 |
| Primary Completion Date: | March 2007 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Midazolam
Pre-anesthetic medication with midazolam, 7.5 mg p.o., 60-90 min prior to estimated induction time
|
Drug: midazolam
midazolam, 7.5 mg p.o., 60-90 min prior to estimated induction time
Other Name: Dormicum
|
|
Active Comparator: Clonidine
pre-anesthetic medication with clonidine, 150 µg p.o., 60-90 min prior to estimated induction time
|
Drug: clonidine
pre-anesthetic medication with clonidine, 150 µg p.o., 60-90 min prior to estimated induction time
Other Name: Catapresan
|
|
Placebo Comparator: Placebo
Pre-anesthetic medication with an inert tablet, p.o., 60-90 min prior to estimated induction time
|
Drug: placebo
inert tablet p.o., 60-90 min prior to estimated induction time
|
Eligibility| Ages Eligible for Study: | 18 Years to 75 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- elective surgery
- ASA physical status I and II
- informed consent
- weight 50 - 100 kg
Exclusion Criteria:
- cardiovascular disease
- pregnancy
- problems of consent due to mentally handicap or language.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00638729
Locations
| Germany | |
| Department of Anaesthesiology and Intensive Care Medicine, University of Schleswig-Holstein Campus Kiel | |
| Kiel, Germany, 24105 | |
Sponsors and Collaborators
University of Schleswig-Holstein
Investigators
| Study Chair: | Jens Scholz, M.D. | Chair of the Dept. of Anaesthesiology and Intensive Care Medicine, University of Schleswig-Holstein Campus Kiel |
More Information
Publications:
| Responsible Party: | Prof. Dr. J. Scholz, Chair of the Department of Anaesthesiology and Intensive Care Medicine, University Schleswig-Holstein Campus Kiel |
| ClinicalTrials.gov Identifier: | NCT00638729 History of Changes |
| Other Study ID Numbers: | A 157/01, A 157/01 |
| Study First Received: | March 12, 2008 |
| Last Updated: | March 18, 2008 |
| Health Authority: | Germany: Federal Institute for Drugs and Medical Devices |
Keywords provided by University of Schleswig-Holstein:
|
bispectral index sedation stress hormones cognitive function |
Additional relevant MeSH terms:
|
Anxiety Disorders Mental Disorders Anesthetics Midazolam Clonidine Central Nervous System Depressants Physiological Effects of Drugs Pharmacologic Actions Central Nervous System Agents Therapeutic Uses Antihypertensive Agents Cardiovascular Agents Sympatholytics Autonomic Agents Peripheral Nervous System Agents |
Adrenergic alpha-2 Receptor Agonists Adrenergic alpha-Agonists Adrenergic Agonists Adrenergic Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Analgesics Sensory System Agents Adjuvants, Anesthesia Anti-Anxiety Agents Tranquilizing Agents Psychotropic Drugs Hypnotics and Sedatives Anesthetics, Intravenous Anesthetics, General |
ClinicalTrials.gov processed this record on May 23, 2013